fda retatrutide CT Health News | Doctors are warning patients against using unapproved versions of retatrutide, an experimental Eli Lilly weight loss drug still in clinical Retatrutide vs Tirzepatide Compared |

Real-World Analysis of Glucagon Like Peptide-1 (GLP-1) Agonist Obesity Treatment Year-Two Clinical and Cost Outcomes (July 2024)

Heres my small take on the GLP 1 revolution

Tirzepatide = GIP + GLP-1 Metabolic strategy : Survodutide adds catabolic/thermogenic mechanisms (glucagon)

Doctors have been raising concerns for years that, while GLP-1 drugs have myriad benefits, they trigger such rapid weight loss that it's hard to preserve muscle or even have the energy to work out

As described by Lilly, retatrutide has a backbone chain of 39 alpha amino acids connected via an isopeptide bond to a second backbone chain that has two or more amino acids: gamma-glutamate, which is an alpha amino acid, and 8-amino-3,6-dioxaoctanoic acid (ADO), which is not

The Phase 3 TRIUMPH clinical trials are scheduled to conclude their primary research phases in late 2026